Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BNang Kuang Pharmaceutical Co., Ltd. 〉Ibandraonte PFS Inj.

Ibandraonte PFS Inj.

Ibandraonte PFS Inj.

Ibandronate is indicated for the treatment and prevention of osteoporosis in post-menopausal women. U.S. Food and Drug Administration (FDA) approved Ibandronate as a daily treatment for post-menopausal osteoporosis.Every participant also received daily oral doses of calcium and 400IUs of vitamin D. At the study's conclusion, both doses significantly reduced the occurrence risk of new vertebral fractures by 50–52 percent when compared to the effects of the placebo drug.

Request for Collaboration
People who like this also like
  • Immurin®(Cyclosporine A)Immurin®(Cyclosporine A)
  • U2 MBC™ KneeU2 MBC™ Knee
  • SB03SB03
  • Fusion Gene TestingFusion Gene Testing
  • PhytoHealth EnerCharge ®CapsulePhytoHealth EnerCharge ®Capsule
  • Miglitol TabletsMiglitol Tablets
  • Anscare LeniScar Silicone StickAnscare LeniScar Silicone Stick
  • BR-FHUS ViewerBR-FHUS Viewer
  • LBx-Liquid BiopsyLBx-Liquid Biopsy
  • Smart Baby MatSmart Baby Mat